Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...
Rechon Life Sciences, a Sweden-based pharma contract manufacturer, was hit with a warning letter from the FDA following an inspection that uncovered unsanitary conditions at its production plant. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results